NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

2–3 year stock research →

7625Listed tickers in the SEC universe 4331Issuers with current reporting periods 1394Issuers with both EPS and ROE metrics 2026-11-04Fundamentals evaluated as of

Example screens

Period 1M3M6M1Y5YMAX
Drawing LineCandles
Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

4331 companies match

Showing 4301–4331 of 4331 · page 87/87

Per page 2550100

Companies with a published price series: 4318 of 4331 · Daily EOD closes from the BibaMoney price store (splits reflected, cash dividends not) · 2026-11-04

YCBD NYSE

cbdMD, Inc.

0.38 -99.98% MAX
Combined rank
—
EPS acceleration
—
ROE
-35.2%
YHC NASDAQ

LQR House Inc.

2.50 -100.00% MAX
Combined rank
—
EPS acceleration
—
ROE
-61.3%
YSWY NASDAQ

Yesway, Inc.

24.77 +16.67% MAX
Combined rank
—
EPS acceleration
—
ROE
—
YUM NYSE

YUM BRANDS INC

155.40 +138.05% MAX
Combined rank
—
EPS acceleration
59.4 pp
ROE
—
YYAI NASDAQ

AIRWA INC.

0.69 -100.00% MAX
Combined rank
—
EPS acceleration
—
ROE
—
ZCSH NYSE

Zcash ETF

32.64 +633.48% MAX
Combined rank
—
EPS acceleration
—
ROE
—
ZDGE NYSE

Zedge, Inc.

2.34 -31.58% MAX
Combined rank
—
EPS acceleration
—
ROE
-0.5%
ZLAB NASDAQ

Zai Lab Ltd

22.07 -18.26% MAX
Combined rank
—
EPS acceleration
—
ROE
-31.0%
ZS NASDAQ

Zscaler, Inc.

237.83 +747.27% MAX
Combined rank
—
EPS acceleration
—
ROE
-2.4%
ZSQR NASDAQ

Z Squared Inc.

3.59 -98.24% MAX
Combined rank
—
EPS acceleration
—
ROE
-13.6%
ZUMZ NASDAQ

Zumiez Inc

15.17 -15.72% MAX
Combined rank
—
EPS acceleration
—
ROE
4.6%
ZURA NASDAQ

Zura Bio Ltd

4.04 -72.92% MAX
Combined rank
—
EPS acceleration
—
ROE
-52.6%
ZVIA NYSE

Zevia PBC

1.19 -91.06% MAX
Combined rank
—
EPS acceleration
—
ROE
-20.6%
ZYME NASDAQ

Zymeworks Inc.

28.61 +120.08% MAX
Combined rank
—
EPS acceleration
—
ROE
-186.6%

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-03. Source: FRED / Federal Reserve.